Cargando…
The role of allopregnanolone in depressive-like behaviors: Focus on neurotrophic proteins
Allopregnanolone (3α,5α-tetrahydroprogesterone; pharmaceutical formulation: brexanolone) is a neurosteroid that has recently been approved for the treatment of postpartum depression, promising to fill part of a long-lasting gap in the effectiveness of pharmacotherapies for depressive disorders. In t...
Autores principales: | Almeida, Felipe Borges, Nin, Maurício Schüler, Barros, Helena Maria Tannhauser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231971/ https://www.ncbi.nlm.nih.gov/pubmed/32435667 http://dx.doi.org/10.1016/j.ynstr.2020.100218 |
Ejemplares similares
-
Allopregnanolone in postpartum depression: Role in pathophysiology and treatment
por: Meltzer-Brody, Samantha, et al.
Publicado: (2020) -
Allopregnanolone: From molecular pathophysiology to therapeutics. A historical perspective
por: Paul, Steven M, et al.
Publicado: (2020) -
Allopregnanolone-based treatments for postpartum depression: Why/how do they work?
por: Walton, Najah, et al.
Publicado: (2019) -
Early postnatal allopregnanolone levels alteration and adult behavioral disruption in rats: Implication for drug abuse
por: Bartolomé, Iris, et al.
Publicado: (2019) -
Pregnane steroidogenesis is altered by HIV-1 Tat and morphine: Physiological allopregnanolone is protective against neurotoxic and psychomotor effects
por: Paris, Jason J., et al.
Publicado: (2020)